UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053937
Receipt number R000061564
Scientific Title The effects of circuit training on cognitive function in healthy individuals
Date of disclosure of the study information 2024/03/21
Last modified on 2024/03/22 09:28:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of circuit training on cognitive function in healthy individuals

Acronym

The effects of circuit training on cognitive function

Scientific Title

The effects of circuit training on cognitive function in healthy individuals

Scientific Title:Acronym

The effects of circuit training on cognitive function

Region

Japan


Condition

Condition

healthy individual

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify how cognitive function changes through habitual exercise (circuit training: resistance training, aerobic exercise, stretching)

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Healthy female participants aged 40 to 74 were subjected to 16 weeks of circuit training, with the aim of comparing changes in cognitive function between the circuit exercise group and the control group.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

Circuit exercises were conducted 2 to 3 times per week for 16 weeks.

Interventions/Control_2

Continuing with their usual lifestyle without engaging in active exercise

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

75 years-old >

Gender

Female

Key inclusion criteria

(1) Age between 40 and under 75 years old (at the time of registration)
(2) Gender: Only females
(3) Individuals who can continue exercising 2 to 3 times a week for 4 months during the study period
(4) Individuals who can provide written consent to participate in the study

Key exclusion criteria

(1) Individuals who cannot obtain informed consent
(2) Individuals with a history of dementia or neurological diseases
(3) Individuals with the following serious diseases or taking medication that could cause such diseases, which will be checked during the consent explanation by the study collaborator:

1. Individuals with a history or current condition of:
Kidney impairment (including severe chronic kidney disease)
Liver impairment
Heart disease
Severe hypertension (systolic blood pressure above 180 mmHg and diastolic blood pressure above 110 mmHg)
Stroke
Mental illness
Epilepsy
Immune diseases
Multiple sclerosis
Systemic lupus erythematosus (SLE)
2. Individuals taking the following medication:
Antiepileptic drugs
Antidepressants
Antipsychotics
Antiarrhythmic drugs
(4) Individuals with severe visual or auditory impairments
(5) Individuals who regularly exercise at sports gyms or clubs
(6) Pregnant or breastfeeding individuals
(7) Individuals participating in other clinical studies (including studies involving exercise intervention or cognitive function tests)
(8) Others who may have difficulty completing the study
(9) Individuals affiliated with the department (including dual appointments) of the study director and co-researchers (students, graduate students, and staff, etc.)
(10) Individuals with claustrophobia
(11) Individuals with metal implants in their body

Target sample size

96


Research contact person

Name of lead principal investigator

1st name Yasuyuki
Middle name
Last name Taki

Organization

Tohoku University

Division name

Smart Aging International Research Center

Zip code

980-8575

Address

4-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi

TEL

022-717-8582

Email

yasuyuki.taki.c7@tohoku.ac.jp


Public contact

Name of contact person

1st name Keishi
Middle name
Last name Soga

Organization

Tohoku University

Division name

Smart Aging International Research Center

Zip code

980-8575

Address

4-1 Seiryo-Machi, Aoba-ku,Sendai

TEL

022-717-8952

Homepage URL


Email

keishi.soga.b4@tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Curves Japan CO.,LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee, Tohoku University Graduate School of Medicine

Address

2-1, Seiryo-machi, Aoba-ku, Sendai

Tel

022-717-8007

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 03 Month 04 Day

Date of IRB


Anticipated trial start date

2024 Year 04 Month 01 Day

Last follow-up date

2026 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 03 Month 21 Day

Last modified on

2024 Year 03 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061564


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name